Utweets
WHAT YOU NEED TO KNOW TODAY! SEE THE ONLY REASON AND FACT NIGERIA PRESIDENT BOLA TINUBU CANNOT BE ARRESTED OR TOUCHED DESPITE HIGHEST LEVEL OF CORRUPTION, EVEN IF HE SELL THE WHOLE OF NIGERIA FOR PERSONAL INTEREST.The National Agency for Food and Drug Administration and Control (NAFDAC) has raised an alarm about the circulation of a counterfeit breast cancer treatment drug, Phesgo 600mg/600mg/10ml, bearing batch number C5290S20. ...Tap To Read The Full Story Here | ..Tap To Read The Full Story Here...
Utweets reports that this warning was issued in a public alert (No. 051/2024), accessible on the agency’s official website.
The issue came to light when a complaint was filed by a doctor at the Lagos University Teaching Hospital (LUTH-NSIA) concerning a suspicious Phesgo product brought in by a patient for treatment. While the drug had not been administered at the time of reporting, its characteristics aligned with a previously identified counterfeit batch, C3809C51.
Roche, the Marketing Authorization Holder (MAH) for Phesgo, investigated images of the suspected counterfeit drug and compared them to genuine samples. The investigation confirmed the batch’s counterfeit status, revealing:
- No batch number in the MAH database
- Discrepancies in labeling and language
- Incorrect tamper-evidence labels
- Missing basilisk and incorrect bollino date
Due to the absence of physical samples for chemical analysis, the investigation was restricted to visual assessments.
Phesgo 600mg/600mg Solution for Injection is a critical medication used to treat breast cancer by targeting and killing cancer cells. NAFDAC warned that counterfeit medicines pose significant health risks, including reduced efficacy and potential harm, as they fail to meet regulatory safety and quality standards.
NAFDAC has instructed all its zonal directors and state coordinators to conduct surveillance and remove any counterfeit products from circulation. It also called on stakeholders in the supply chain—including importers, distributors, retailers, and healthcare providers—to remain vigilant and ensure they source medications only from authorized suppliers.
Reporting and Consumer Safety
NAFDAC urged healthcare professionals and the public to report suspicions of counterfeit or substandard medicines to the nearest NAFDAC office. Reports can also be made through the following channels:
The agency emphasized that adverse effects linked to medical products should also be reported promptly to ensure timely action.
NAFDAC confirmed that the details of the counterfeit product would be uploaded to the World Health Organization (WHO) Global Surveillance and Monitoring System (GSMS) for further international awareness and monitoring.WHAT YOU NEED TO KNOW TODAY! SEE THE ONLY REASON AND FACT NIGERIA PRESIDENT BOLA TINUBU CANNOT BE ARRESTED OR TOUCHED DESPITE HIGHEST LEVEL OF CORRUPTION, EVEN IF HE SELL THE WHOLE OF NIGERIA FOR PERSONAL INTEREST.
This alert underscores the critical need for vigilance in the healthcare sector to combat the circulation of counterfeit drugs and protect public health….Tap To Read The Full Story Here.
